Author:
Figg William D.,Reed Eddie,Green Shawn,Pluda James M.
Reference84 articles.
1. Fabro, S., Smith, R. L., and Williams, R. T. (1967) Toxicity and teratogenicity of optical isomers of thalidomide. Nature 215(98), 296.
2. Anonymous (1990) Medical news and perspectives: Thalidomide’s back in the news, but in more favorable circumstances. JAMA 263, 1467,1468.
3. Schumacher, H., Smith, R. L., and Williams, R. T. (1965) The metabolism of thalidomide and some of its hydrolysis products in various species. Br. J. Pharmacol. 25, 338–351.
4. Simmons, B. R., Lush, R. M., and Figg, W. D. (1965) A reverse-phase HPLC method using solid phase extraction for quantitating thalidomide. Anal. Chim. Acta 339, 91–97.
5. Bauer, K. S., Dixon, S. C., and Figg, W. D. (1998) Inhibition of angiogenesis by thalidomide requires metabolic activation which is species-dependent. Biochem. Pharmacol. 55, 1827–1834.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献